25 C
Vientiane
Friday, April 25, 2025
spot_img

Cision PR Newswire

Akeso Announces FDA Approval for Penpulimab-kcqx in Two BLA Indications for Comprehensive Treatment of Advanced Nasopharyngeal Carcinoma

HONG KONG, April 25, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that the U.S. Food and Drug Administration (FDA) has approved its differentiated PD-1 monoclonal antibody, penpulimab-kcqx, in combination with cisplatin or carboplatin and gemcitabine for the first-line treatment of adult recurrent...

A Visionary Breakthrough: VISTA Eye Specialist and EssilorLuxottica Join Forces to Combat Childhood Myopia in Malaysia

PETALING JAYA, Malaysia, April 25, 2025 /PRNewswire/ -- In a landmark move to safeguard...

ZERO BREEZE Partners with NASCAR Driver Patrick Emerling to Bring Cooling Innovation to the Track

LINCOLN, Ala., April 25, 2025 /PRNewswire/ -- ZERO BREEZE, a leader in portable air conditioning...

Theo Raises $20M to Democratize Access to Institutional-Grade Trading Infrastructure

Founded by ex-Optiver and IMC quants, the platform is backed by angels from Citadel,...

MicroCloud Hologram Inc. plans to adopt deepseek R1 as the basis for holographic AI applications to provide users with holographic intelligence experience

SHENZHEN, China, Jan. 27, 2025 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, announced plans to adopt...

Qiming Venture Partners’ Portfolio Company HyperStrong Successfully Listed on STAR Market

SHANGHAI, Jan. 27, 2025 /PRNewswire/ -- On January 27th, 2025, Beijing Time, Qiming Venture Partners' portfolio company HyperStrong, a leading provider of battery energy storage...